Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sepranolone - Asarina Pharma

X
Drug Profile

Sepranolone - Asarina Pharma

Alternative Names: Isoallopregnanolone; UC-1010

Latest Information Update: 06 Apr 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Umecrine Mood
  • Developer Asarina Pharma
  • Class Antidepressants; Antimigraines
  • Mechanism of Action GABA A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Gilles de la Tourette's syndrome; Menstrual migraine; Premenstrual dysphoric disorder

Most Recent Events

  • 31 Mar 2023 Phase-II clinical trials in Gilles de la Tourette's syndrome (In children, In adults) in Denmark (SC)(NCT05434546)
  • 31 Mar 2023 Asarina Pharma completes a phase II trial in Gilles-de-la-Tourette's-syndrome in Denmark (NCT05434546)
  • 15 May 2021 Asarina Pharma and Scandinavian CRO complete a phase II trial in Menstrual migraine (In adults) in Finland and Sweden (SC) (NCT04102995) (EudraCT 2019-001081-15)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top